Ayer Capital Management, LP
Follow13F filer, CIK 1471149, SAN FRANCISCO, CA
Ayer Capital Management, LP reported $26,825,000 across 2 holdings for the quarter ended 2015-06-30, in a 13F-HR filed 2015-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001140361-15-032327
- Period
- 2015-06-30
- Reported value
- $26.8M
- Holdings
- 2
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| Lion Biotechnologiesreduced | -2,780,682 | -$25.5M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2015
Share positions as resolved from 13F-HR 0001140361-15-032327, largest first. % of portfolio is the value over $26,825,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| Lion BiotechnologiesLion Biotechnologies | 2,823,333 | $25.9M | 96.51% | -2,780,682 | |||
| ONCOTHYREON INCONCOTHYREON INC | 250,000 | $935K | 3.49% | 0 |
How Q2 2015 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001140361-15-032327 | base | 2015-08-14 | acceptance time not in the bulk data set |